Tru Kidney Health Test Panel and 1 more
Alkaline Picrate, Colorimetry, Creatinine. 510(k) K251058, from Truvian Health (San Diego, CA). Product code CGX, class 2.
As of Nov 17, 2026, K251058 is an FDA 510(k) held by Truvian Health, substantially equivalent on Nov 26, 2025 after 236 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Nov 26, 2025
- Review time: 236 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Tru Kidney Health Test Panel is part of the TruWellness Panel™ and is intended for use on the Tru Analyzer. The Tru Kidney Health Test Panel (part of the TruWellness Panel™) is an in vitro diagnostic device and intended to be used for the quantitative determination of Creatinine (CRE) and Blood Urea Nitrogen (BUN) in lithium-heparinized venous whole blood in clinical laboratory or…
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Atellica® CH Creatinine_3 (Crea3)K242685 · Siemens Healthcare Diagnostics, Inc. · Dec 4, 2024
- Comprehensive Metabolic Panel, skyla Clinical Chemistry Analyzer, Minicare C300 Clinical…K171971 · Lite-On Technology Corp. H.S.P.B. · Jan 25, 2018
Other CGX Clearances
The newest 510(k)s for the same product code; see every CGX device- Atellica® CH Creatinine_3 (Crea3)K242685 · Siemens Healthcare Diagnostics, Inc. · Dec 4, 2024
- Creatinine2K210452 · Abbott Ireland Diagnostics Division · Mar 22, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 4, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files